Latest filing published 26 Jul 2021 for Hamlet Pharma AB, €487.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mats Otto Persson: trading record in brief
Mats Otto Persson discloses dealings in Hamlet Pharma AB to Finansinspektionen. Over a trading history stretching from 24 May 2017 to 23 July 2021, the count stands at 4 filings.
Purchases make up the whole of the open-market record (2 purchases, €61.7M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants. So far in 2021, the count stands at 1 purchase and no sales.
The latest filing, published on 26 July 2021, reports a share grant of €487 in Hamlet Pharma AB. The latest purchase dates back some time: it was published 1,930 days ago, on 26 July 2021. The median gap between a trade and its publication by Finansinspektionen is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Mats Otto Persson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 384 shares@ SEK 13.000.0% of flowBTU (betald tecknad unit)FI:csv-96847591b76a4e353d62
- 769 shares@ SEK 13.000.0% of flowBTU (betald tecknad unit)FI:csv-d1b11aeb14c80ebf3478
- 10,000 shares@ SEK 6.500.0% of flowBTA (betald tecknad aktie)ISIN SE0016609358FI:csv-3ab45c31908e28e7e50dCanonical exit: 21 Oct 2021 (T+90)
- 10,000 shares@ SEK 60,000.00100.0% of flowFI:csv-d03e98375ab18b2d488aCanonical exit: 22 Aug 2017 (T+90)
4 of 4 declarations